Content area
Full text
Known for its expertise in developing targeted and immunology-based cancer treatments, BeiGene is adding Medidata’s electronic patient-reported outcome solution to clinical studies in that field.
BeiGene will integrate data received through Medidata’s Patient Cloud ePRO into its electronic data capture platform called Rave. The infusion will improve operational efficiency, reduce transcription errors and reconciliation issues, and decrease data quality risk plans, Medidata said in a .
“By automating paper-based procedures and centralizing patient data on the Medidata platform, we’re able to collaborate globally on our oncology research,” said Ross Pettit, SVP...